Day: March 3, 2026

Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario’s Weight Management

As oral GLP-1s enter the market with slightly more modest weight and glycemic outcomes than injectable formulations, Dario integrates structured...

Black Book Releases 2026 PAIR Benchmark Ahead of HIMSS26, Quantifying “Last-Mile” Prior Authorization and Interoperability Readiness Across Payers, Providers, and Vendors

PAIR Benchmark scores overall readiness at 58/100, with ~35-40% provider-side manual fallback and only ~20% reporting SLO-grade monitoring and runbooks....

error: Content is protected !!